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Actin cytoskeleton remodeling is well known to be positively
involved in glucose-stimulated pancreatic  cell insulin secre-
tion. We have observed glucose-stimulated focal adhesion
remodeling at the  cell surface and have shown this to be cru-
cial for glucose-stimulated insulin secretion. However, the
mechanistic link between such remodeling and the insulin
secretorymachinery remained unknown and was themajor aim
of this study. MIN6B1 cells, a previously validatedmodel of pri-
mary  cell function, were used for all experiments. Total inter-
nal reflection fluorescence microscopy revealed the glucose-re-
sponsive co-localization of focal adhesion kinase (FAK) and
paxillinwith integrin1 at the basal cell surface after short term
stimulation. In addition, blockade of the interaction between1
integrins and the extracellular matrix with an anti-1 integrin
antibody (Ha2/5) inhibited short term glucose-induced phos-
phorylation of FAK (Tyr-397), paxillin (Tyr-118), and ERK1/2
(Thr-202/Tyr-204). Pharmacological inhibition of FAK activity
blocked glucose-induced actin cytoskeleton remodeling and
glucose-induced disruption of the F-actin/SNAP-25 association
at the plasma membrane as well as the distribution of insulin
granules to regions in close proximity to the plasmamembrane.
Furthermore, FAK inhibition also completely blocked short
term glucose-induced activation of the Akt/AS160 signaling
pathway. In conclusion, these results indicate 1) that glucose-
induced activation of FAK, paxillin, and ERK1/2 is mediated by
1 integrin intracellular signaling, 2) a mechanism whereby
FAK mediates glucose-induced actin cytoskeleton remodeling,
hence allowing docking and fusion of insulin granules to the
plasmamembrane, and 3) a possible functional role for the Akt/
AS160 signaling pathway in the FAK-mediated regulation of
glucose-stimulated insulin secretion.
Pancreatic cells and their secretory product insulin are cen-
tral to the pathogenesis of both major types of diabetes. Exocy-
totic release of insulin is triggered by enhanced glucose metab-
olism by the  cell followed by increased intracellular ATP/
ADP ratios, closure of ATP-sensitive K channels, membrane
depolarization, opening of voltage-gated Ca2 channels, and
increased intracellular Ca2 concentrations (1–5). A second
mechanism serves to amplify glucose-stimulated insulin secre-
tion (GSIS),2 acting in synergy with this canonicalKATP-depen-
dent pathway that is seen as the trigger (6). More than 40 years
ago Curry et al. (7) demonstrated that insulin secretion in
response to glucose exhibits a biphasic pattern consisting of a
rapidly initiated and transient first phase followed by a gradu-
ally developing and sustained second phase. The ability of glu-
cose to elicit first phase insulin secretion is shared by other
stimuli such as high KCl stimulation, resulting in membrane
depolarization. However, only fuel secretagogues will also ini-
tiate second-phase insulin release (6).
Grodsky et al. (8, 9) were the first to propose an insulin stor-
age-limited mathematical model with functionally distinct
pools of granules to explain the biphasic kinetics of secretion in
pancreatic  cells. This model was more recently confirmed
using newly developed methods that allow the study of exocy-
tosis and intracellular granule trafficking in individual cells (for
review, see Ref. 10). These experiments show that first-phase
release is ascribed to Ca2-dependent exocytosis of primed
granules in a small readily releasable pool, whereas the second
phase of secretion requires anATP-dependent recruitment of a
reserve pool of secretory granules to the release site (10, 11).
Insulin granule exocytosis requires docking and fusion of
secretory vesicles with the release sites at the plasma mem-
brane. This is mediated by core machinery of membrane-asso-
ciated SNAP receptors (SNAREs) which can be classified into
two subfamilies: vesicle-SNAREs (found on the vesicles) and
target-SNAREs (t-SNAREs, found on target membranes) (12).
In  cells the vesicle-SNARE protein VAMP-2 is shown to
interact specifically with the t-SNARE proteins syntaxin1 and
synaptosome-associated protein of 25 kDa (SNAP-25) upon
trafficking of a vesicle to a target membrane, bringing the two
membranes into close proximity to allow fusion (13–15).
Earlier studies demonstrated that isolated insulin-containing
granules co-sediment with filamentous actin (F-actin) (16),
which is organized as a dense web beneath the plasma mem-
brane, blocking access of secretory vesicles to the cell periphery
(16–19). Additionally, in the non-stimulated condition F-actin
was found to be associated with the t-SNARE complex, thereby
blocking the latter, whereas glucose stimulation has been
shown to induce F-actin remodeling (20–22), transient disrup-
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tion of the t-SNARE/F-actin association, and redistribution of
insulin-containing granules tomore peripheral regions of the 
cell (21), hence facilitating insulin secretion.
Actin cytoskeleton remodeling is a well described feature
involved in spreading and migration of cells and has been
shown to be regulated by focal adhesionmolecules such as focal
adhesion kinase (FAK) and paxillin (23). Thesemoleculesmake
up focal contact sites, providing not only a structural link
between the extracellular matrix (ECM) and cytoskeletal pro-
teins but serving also as initiation points for outside-in signal-
ing leading to changes in cell activity and gene expression (24–
26). We recently demonstrated a functional role for focal
adhesion remodeling andmore specifically for FAKandpaxillin
in GSIS of  cells (27). We have also shown that ERK1/2 acti-
vation is critical for both GSIS and actin remodeling (22). How-
ever, the directmechanistic link between these various facets of
the regulation of insulin secretion from  cells has yet to be
elucidated.
The aim of this study was to further explore the glucose-
activated FAK-paxillin-ERK1/2 signaling pathway in  cells.
We demonstrate here the involvement of 1 integrin and illus-
trate a link between glucose-induced actin cytoskeleton remod-
eling and the induced translocation and activation of FAK, pax-
illin, and ERK1/2. Finally, we focus specifically on FAK and
unveil a mechanistic link between FAK activity and the regula-
tion of GSIS involving actin remodeling and the Akt/AS160
signaling pathway.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—The selective FAK inhibitor,
1,2,4,5-benzenetetraamine tetrahydrochloride (Y15) was pur-
chased from Sigma and used at 1 M final concentration. Pri-
mary antibodies were: rabbit anti-FAK polyclonal antibody
(pAb) from Santa Cruz Biotechnology (Santa Cruz, CA), rabbit
anti-phospho(Tyr-397)FAKpAb and rabbit anti-phospho(Tyr-
118)paxillin pAb from Invitrogen, mouse anti-paxillin mono-
clonal antibody, rat anti-CD29 (1 integrin chain, Ha2/5), and
control hamster IgM from BD Transduction Laboratories, and
rabbit anti-ERK1/2 pAb, rabbit anti-phospho-ERK1/2 pAb,
and rabbit anti-myc-tag pAb from Cell Signaling Technology
(Beverly, MA). The monoclonal SNAP-25 antibody used for
coimmunoprecipitationwas obtained fromSternbergerMono-
clonals, Inc. (Lutherville, MD). Secondary antibodies were as
follows: donkey anti-rabbit horseradish peroxidase (HRP) and
sheep anti-mouse HRP (Amersham Biosciences) and donkey
anti-rabbit Alexa Fluor 488 and donkey anti-mouseAlexa Fluor
555 (Invitrogen). To visualize F-actin, Alexa Fluor 647-phalloi-
din was obtained from Invitrogen. NSC23766, latrunculin B,
and jasplakinolide were from Calbiochem.
Cell Lines and Culture Conditions—MIN6B1 cells were cul-
tured in complete medium as previously described (28). For
total internal reflection fluorescence (TIRF) microscopy and
confocal live imaging, cells were plated on 35-mmglass-bottom
microwell dishes (MatTek, Ashland, MA) coated with the
extracellular matrix from 804G rat bladder carcinoma cells to
favor cell attachment (29).
Expression Vectors—To obtain an extracellularly fluores-
cently tagged 1A integrin (pEGFPnhu1A), the EGFP
sequence was cloned into a flexible loop in the 1 hybrid
domain using AgeI/XhoI sites previously inserted by primer
overlap extension mutagenesis. The construct was tested by
transient overexpression in 3T3 fibroblasts, where it localized
to focal and fibrillar adhesions (data not shown). Neuropeptide
Y (NPY)-Cherry was a gift from Prof. Guy A. Rutter (Imperial
College London). The pEGFPC1-FAK plasmid was a gift from
Prof. David D. Schlaepfer (University of California). cDNA
encoding paxillin was excised from the paxillin-pEGFP plasmid
(AddGene) and cloned into the pDsRed-monomer plasmid.
The plasmid expressing Lifeact-mRFPruby was a gift from Dr.
Roland Wedlich-Soldner (Max Planck Institute of Biochemis-
try). The plasmid encoding myc-tagged wild type Rac1 was
kindly provided by Dr. Romano Regazzi (University of Laus-
anne, Switzerland).
SDS-PAGEandWesternBlotting—Protein sampleswere pre-
pared, and immunoblots were analyzed as described (27).
Western blots were quantified by densitometry, and band den-
sity of phosphoproteins was normalized to that of the corre-
sponding total protein as indicated in the figures.
Ha2/5-mediated Blocking of1 Integrin—MIN6B1 cells were
resuspended at a density of 106 cells/ml in complete culture
medium and preincubated for 1 hwith 4g/ml anti-1 integrin
blocking antibody (Ha2/5) or purified hamster IgM. Then cells
were plated as droplets on dishes coated with 804Gmatrix and
incubated for 5 h at 37 °C in the presence of the respective
antibodies. Finally, cells were treated as described, and lysates
were analyzed by SDS-PAGE and Western blotting.
Coimmunoprecipitation—Coimmunoprecipitations were per-
formed as described by Thurmond et al. (21). After the indi-
cated treatments, cells were solubilized in Nonidet P-40 deter-
gent lysis buffer (25 mM Tris, pH 7.4, 1% Nonidet P-40, 10%
glycerol, 50 mM NaF, 10 mM Na4P2O7, 137 mM NaCl, 1 mM
Na3VO4, 1 mM PMSF) supplemented with CompleteMini pro-
tease inhibitor mixture. Cell lysates were first preincubated
with protein G Plus Agarose (Santa Cruz Biotechnology) for 30
min at 4 °C. Cleared lysates were then combined with 1 g of
SNAP-25 monoclonal antibody for 2 h at 4 °C followed by an
incubation with protein G Plus-agarose for 2 h at 4 °C. After
centrifugation, removal of the supernatant, and five washing
steps in lysis buffer, the immunoprecipitates were resuspended
in SDS-PAGE sample buffer, boiled for 5 min, and subjected to
SDS-PAGE and Western blotting.
Immunofluorescence and Confocal Microscopy—Immuno-
fluorescence was performed as previously described (22). Cells
were observed under a Zeiss LSM510 Meta confocal micro-
scope using a 63 oil immersion lens. Images were acquired
and processed using the LSM510 software (Carl Zeiss AG).
Confocal live imaging was performed with a Nikon A1r micro-
scope (Nikon, Tokyo, Japan) by using a 60 CFI plan Apo
objective and a filter optimized formCherry fluorescence. Cells
posed on 804G-coated glass-bottom culture dishes were placed
on the microscope stage and maintained at 37 °C and 5% CO2.
Transfected cells were chosen at random for analysis and
images were captured every 60 s.
TIRF Microscopy—Cells were transfected using Lipo-
fectamineTM 2000 reagent (Invitrogen) using the manufactur-
er’s instructions. Transfected cells were incubated for 48 h to
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allow for DNA expression and were then treated (as indicated)
and fixed. TIRF images of NPY-Cherry fluorescence were
obtained with a Plan Neofluar  100 (NA 1.45) objective
mounted on an Axiovert 100M (both from Carl Zeiss Micro-
Imaging) equipped with a 12-bit digital charge-coupled device
camera (model Orca 4742–95; Hamamatsu Photonics) and
controlled by the Openlab software (Improvision). Intraobjec-
tive TIRF was obtained with a 535-nm laser through a TIRF
adaptor (TILL Photonics).
Insulin Secretion Assays—Insulin secretion assays were per-
formed as previously described (22).
StatisticalAnalyses—The statistical significance of the differ-
ences between the experimental conditions was determined by
Student’s t test for unpaired groups. p values less than 0.05were
considered significant.
RESULTS
1 Integrin Co-localizes with FAK and Paxillin at Basal Cell
Membrane of MIN6B1 Cells after Glucose Stimulation—We
have shown previously that both focal adhesion proteins FAK
and paxillin are important players in the regulation of GSIS in
primary rat  cells (27). We have also demonstrated that the
highly differentiated MIN6B1 mouse  cell line subcloned in
our laboratory responds to glucose with a robust increase in
insulin secretion (28). Furthermore, and of particular impor-
tance for this study, our earlier work indicates that MIN6B1
cells are a useful model to study  cell exocytosis, with a very
similar pattern of biochemical and morphological changes
observed in response to glucosewhen comparedwith primary
cells (20–22, 27). However, note that MIN6B1 cells exhibit
higher and, depending on the batch and passage, more variable
basal insulin secretion (as the percentage of cellular insulin con-
tent) than primary  cells. Given the technical challenge in
obtaining pure primary  cells in sufficient quantity for the
detailed biochemical studies performed here, all experiments
were done using MIN6B1 cells as a validated model of primary
 cells.
To further explore the signaling pathway(s) involved in glu-
cose-induced phosphorylation and activation of FAK, paxillin,
and ERK1/2 in  cells posed on a matrix produced by the rat
bladder carcinoma cell line 804G (27), we determined whether
integrins might be involved in this process. It has been demon-
strated previously that integrins of the 1 family impact  cell
function and survival in a beneficial way (30–32). In view of
these findings, we co-transfected MIN6B1 cells with plasmids
expressing 1 integrin-EGFP or FAK-EGFP and paxillin-dsRed
and analyzed the subcellular localization of these fusion pro-
teins at the basal cell surface (defined as the cell membrane in
FIGURE 1. 1 integrin co-localizes with FAK and paxillin at the basal membrane of MIN6B1 cells. TIRF analysis of the subcellular localization of 1
integrin-EGFP (green, top andmiddle panels (A–C)) and paxillin-dsRed (red) and FAK-EGFP (green, bottompanels (D)) inMIN6B1 cells with orwithout stimulation
for 10 min with 20mM glucose or 40 mM KCl is shown. Themerged panels show 1 integrin or FAK co-localization with paxillin. Scale bars, 10m. All pictures
are fully representative of multiple images of two independent experiments.
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direct contact with the ECM) by TIRF microscopy. This tech-
nique enables examination of specifically the bottom 100 nm of
a spreading cell (33). For this purposeMIN6B1 cells were taken
48 h after co-transfection, preincubated for 2 h at 0mM glucose,
and further incubated for 10 min at 0 mM glucose, 20 mM glu-
cose, or 40 mM KCl. In the basal condition (0 mM glucose), 1
integrin co-localizes with paxillin at few specific sites at the
basal cell membrane (Fig. 1A, upper panels). However, upon
short term glucose and KCl stimulation, we observed a strik-
ing increase in the number of sites at the basal cell membrane
where 1 integrin and paxillin were co-localized (Fig. 1, B
and C, middle panels). Further analysis also indicated the
presence of FAK along with paxillin at these specific sites
(Fig. 1D, lower panels), suggesting a functional interaction
between 1 integrin, FAK, and paxillin at these previously
defined focal adhesion sites that develop rapidly in response
to glucose (27).
Blocking 1 Integrin Inhibits Glucose-induced Phosphoryla-
tion of FAK, Paxillin, and ERK1/2—The fact that 1 integrin
co-localizes with FAK and paxillin at specific focal contact sites
led us to investigate the effect of blocking 1 integrin on glu-
cose-induced phosphorylation and activation of FAK and pax-
illin and their downstream signaling effector, ERK1/2. We,
therefore, used a specific anti-1 integrin blocking antibody
(Ha2/5) previously shown to significantly inhibit GSIS and 
cell spreading (30). We then analyzed the phosphorylation
status of FAK, paxillin, and ERK1/2 in MIN6B1 cells prein-
cubated with Ha2/5 antibody (or control IgM) in the basal (0
mM glucose) and stimulated (10 min at 20 mM glucose) con-
ditions. In the control situation (IgM), glucose stimulation
resulted in a clear phosphorylation of FAK, paxillin, and
ERK1/2 as compared with the basal condition (Fig. 2, A and
B), which correlates with our previous findings in primary 
cells (27). However, blocking 1 integrin (Ha2/5) signifi-
cantly decreased glucose-induced phosphorylation of FAK,
paxillin, and ERK1/2 by 43.8 6.9% (p 0.01), 40.1 11.5%
(p 0.05), and 47.4 14.3% (p 0.05) respectively as com-
pared with the control stimulated condition (IgM, 20 mM
glucose) (Fig. 2,A and B). These results show that 1 integrin
signaling is involved in glucose-induced phosphorylation
and activation of ERK1/2 and the two focal adhesion pro-
teins, FAK and paxillin. Finally, further analysis also revealed
a significant inhibition of the basal phosphorylation of FAK,
paxillin, and ERK1/2 by blocking 1 integrin (Ha2/5, 0 mM
glucose) as compared with the control basal condition (IgM,
0 mM glucose), which, as regards FAK, correlates with earlier
data reported by Parnaud et al. (30) showing the effect of this
same anti-1 integrin antibody on  cell spreading.
FIGURE 2.Blocking1 integrin inhibits glucose-inducedphosphorylationof FAK, paxillin, andERK1/2 inMIN6B1 cells.A, lysates ofMIN6B1 cells treated
with a control (IgM) or anti-1 integrin (Ha2/5) antibody and kept at 0mMglucose or stimulated for 10minwith 20mMglucosewere analyzed byWestern blot
using the indicated antibodies. A representative blot from four independent experiments is shown. B, the relative intensities of the phosphorylated and total
protein bands of the basal and stimulated conditions were quantified by densitometry and expressed as a ratio. Ratios were normalized to control (IgM)
glucose-stimulated cells. Data are the means S.E. from four independent experiments (*p 0.05, **p 0.01, and ***p 0.001).
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Induced Actin (De)polymerization Affects Glucose-induced
Phosphorylation of FAK, Paxillin, and ERK1/2—In endothelial
cells, integrin receptors located in focal adhesion complexes are
known to be crucial in regulating cell-ECM interactions (34)
andmediating FAK activation (35, 36). Activated FAK together
with downstream focal adhesion complex-linked cytoskeletal
proteins such as paxillin thereby form a mechanical link
between the ECMand the cell actin cytoskeleton (37). To deter-
mine a possible role for actin and more specifically its poly-
merization state in the regulation of glucose-induced activation
of FAK, paxillin, and ERK1/2 in cells, we analyzed the effect of
the actin-disrupting agents latrunculin B and jasplakinolide on
glucose-stimulatedMIN6B1 cells. Previously, both compounds
have been reported to potentiate GSIS by disrupting the
dynamic equilibrium of the actin polymerization state between
monomeric G-actin and filamentous F-actin (20–22).
We show here that exposure of MIN6B1 cells to the actin
depolymerizing agent latrunculin B significantly inhibits glu-
cose-induced phosphorylation of FAK and paxillin by 77.1 
7.6% (p  0.01) and 85.8  1.6% (p  0.001), respectively, as
compared with the control stimulated condition (Fig. 3A). Glu-
cose-induced phosphorylation of ERK1/2 on the other hand
was confirmed to be potentiated by latrunculin B, as described
by us previously (22) (data not shown). Similar to latrunculin B,
MIN6B1 cells treated with the actin filament stabilizing com-
pound jasplakinolide also showed a significant decrease in glu-
cose-induced phosphorylation of FAK and paxillin by 78.6 
5.1% (p  0.001) and 86.7  3.3% (p  0.001), respectively, as
compared with the control stimulated condition (Fig. 3B).
However, in contrast to latrunculin B, pretreatment with jas-
plakinolide resulted in a significant decrease (42.1 12.6%, p
0.05) in glucose-induced phosphorylation of ERK1/2 as com-
pared with control stimulated cells (Fig. 3B, right panels).
We next determined the effect of actin depolymerization
induced by latrunculin B on the subcellular localization of the
phosphorylated isoforms of FAK, paxillin, and ERK1/2 in
MIN6B1 cells. In the control glucose-stimulated condition (20
mM glucose), both phospho-FAK, phospho-paxillin and phos-
pho-ERK1/2, localized, as earlier described in rat primary 
cells (27), in numerous focal adhesion sites formed at the tips of
actin fibers (Fig. 4, left panels). Treatment with latrunculin B
has been previously demonstrated to disrupt the actin cytoskel-
eton,with F-actin fragmented and scattered throughout the cell
(22). We observed that this coincides with a clear loss in well
FIGURE 3. The effect of latrunculin B and jasplakinolide on glucose-induced phosphorylation of FAK, paxillin, and ERK1/2. A, MIN6B1 cells were
preincubated for 2 h in the presence of 0mM glucose combinedwith the actin depolymerizing agent latrunculin B (10M, or DMSO as a negative control) and
were further stimulated for 10 min with 20 mM glucose containing latrunculin B (or DMSO). Cell lysates were analyzed by Western blot with the indicated
antibodies, and a representative blot from three independent experiments is shown. Relative intensities of the phosphorylated and total protein bands were
quantifiedbydensitometry and expressed as a ratio. Ratioswere thennormalized to the control highglucose (20mMglucose) condition. Data are themeans
S.E. fromthree independentexperiments (*p0.01and**p0.001).B,MIN6B1cellswere incubatedandanalyzedas abovebutwith theactin stabilizingagent
jasplakinolide (5 M, or DMSO as a negative control). Data are the means S.E. from three independent experiments (*, p 0.05; **, p 0.001).
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defined phospho-FAK-, phospho-paxillin-, and phospho-
ERK1/2-containing focal adhesions (Fig. 4, right panels), indi-
cating the absence of glucose-induced FAK, paxillin, and
ERK1/2 translocation to focal adhesion sites upon inhibition of
dynamic actin remodeling normally mediated by physiological
signals that result from glucose stimulation. Increased amounts
of phosphorylated ERK1/2 upon latrunculin B treatment, as
shown byWestern blot by Tomas et al. (22), were not observed
by immunolocalization. This is probably due to the latrunculin
B-induced disorganization of focal adhesions resulting in a dif-
fuse signal for phosphorylated ERK1/2. Furthermore, analysis
of the subcellular localization of all three proteins in the pres-
ence of jasplakinolide revealed an effect of actin filament stabi-
lization on glucose-induced mobilization of FAK, paxillin, and
ERK1/2 that was very similar to that seenwith latrunculin B-in-
duced actin depolymerization (data not shown).
These data suggest that by interfering with the dynamic
integrity of the actin cytoskeleton, both stabilization and inhi-
bition of actin polymerization can block translocation of FAK
and paxillin to focal adhesion sites, thereby also inhibiting their
glucose-induced phosphorylation and activation. By contrast,
glucose-induced phosphorylation of ERK1/2 is potentiated by
actin depolymerization and inhibited by actin filament stabili-
zation, whereas its glucose-inducedmobilization to focal adhe-
sion sites is inhibited by both conditions.
FAK Inhibition Blocks Glucose-induced Actin Cytoskeleton
Remodeling—To establish to which extent FAK activity is
required for F-actin cytoskeleton organization and remodeling
in glucose-stimulated  cells, we analyzed the F-actin fiber
structure (stained with phalloidin) at the basal plane and the
midplane ofMIN6B1 cells stimulatedwith 20mMglucose in the
presence of the selective FAK inhibitor, compound Y15 (1 M,
or DMSO as a negative control), which specifically inhibits
FAK-Tyr-397 autophosphorylation (38, 39) (Fig. 5A). As previ-
ously reported (21, 22) and as shown in the lower left panel of
Fig. 5A, MIN6B1 cells in the basal condition (0 mM glucose)
display shorter, more dense actin filaments at the basal plane,
whereas short term stimulation with 20 mM glucose resulted in
a partial depolymerization of the  cell actin cytoskeleton as
comparedwith the basal condition (0mM glucose). However, in
the presence of compound Y15, the actin cytoskeleton
remained largely unchanged upon glucose stimulation (Fig. 5A,
lower right panel), suggesting that FAK activity is required for
glucose-induced F-actin remodeling. Analysis of the midplane
of the cells revealed that in the basal condition (0 mM glucose,
upper left panel of Fig. 5A)MIN6B1 cells display an intense and
nearly continuous band of F-actin staining that was locally dis-
rupted upon glucose stimulation (20 mM glucose). Similar to
the basal plane, this glucose-induced remodeling process was
largely inhibited by treatment of the cells with compound Y15
(Fig. 5A, upper right panel), indicating that F-actin at the mid-
plane is equally responsive to glucose stimulation and FAK
inhibition (Fig. 5A, upper panels) as compared with actin
remodeling at the basal membrane.
This was further confirmed inMIN6B1 cells transfectedwith
a construct expressing Lifeact-mRFP. Lifeact is a 17-amino acid
peptide that stains F-actin structures without interfering with
actin dynamics in vitro and in vivo, thereby allowing live imag-
ing of actin dynamics (40). Two days after transfection, cells
were preincubated for 2 h at 0mM glucose combinedwith com-
pound Y15 (1 M, or DMSO as a negative control) and were
further stimulated for 10 min with 20 mM glucose in the pres-
ence of Y15 (orDMSO). In controlMIN6B1 cells (Fig. 5B,upper
panels; see also supplemental Movie 1), we observed clear actin
FIGURE 4.Effect of latrunculinB-inducedactindepolymerizationonglucose-mediated translocationof FAK, paxillin, andERK1/2.MIN6B1 cells treated
with or without latrunculin B were stimulated for 10 min with 20 mM glucose, fixed, and triple-stained for F-actin (blue), paxillin (red), and phospho-FAK,
phospho-paxillin or phospho-ERK1/2 (green), respectively. All pictures are fully representative of multiple images from three independent experiments. Scale
bars, 5 m.
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fiber remodeling shortly after glucose stimulation, whereas this
process was markedly inhibited in MIN6B1 cells treated with
compound Y15 (Fig. 5B, lower panels, see also supplemental
Movie 2). Taken together, these results indicate that FAK activ-
ity has an important regulatory role in glucose-induced actin
cytoskeleton remodeling inMIN6B1 cells, comparable with the
role of FAK in insulin-induced actin reorganization in muscle
cells (41).
FAK Inhibition Stabilizes Interaction between F-actin and
SNAP-25—F-actin has been shown to associate in a glucose-
responsivemanner with the t-SNARE proteins syntaxin 1A and
SNAP-25, limiting the rate and extent of insulin release in 
cells (21). To determine whether FAK activation and its role in
actin cytoskeleton remodeling represent a regulatory step in
F-actin/t-SNARE complex association, we immunoprecipi-
tated SNAP-25, reflective of this complex (21), from MIN6B1
cells extracted after glucose stimulation (10 min at 20 mM glu-
cose) in the presence or absence of the FAK inhibitor com-
pound Y15 (1 M) (Fig. 6A). Quantification of the amount of
coimmunoprecipitated actin indicated as previously shown
(21) a significant decrease (36.2 10.8%, p 0.05) in F-actin/
SNAP-25 association upon glucose stimulation, as compared
with the control condition (0 mM glucose) (Fig. 6B). However,
treatment ofMIN6B1 cells with compoundY15 (1M) resulted
in a 74.5 17.2% (p 0.05) increase in F-actin/SNAP-25 asso-
ciation as compared with the control stimulated condition (20
mM glucose) (Fig. 6B). These data suggest that FAK inhibition
might affect the functionality of t-SNARE complexes and,
thereby, GSIS through a decrease in glucose-induced F-actin
depolymerization in  cells.
Inhibition of FAK Decreases the Number of Morphologically
Docked Insulin Granules at Plasma Membrane—We recently
demonstrated that FAK inhibition in rat primary  cells
decreases insulin secretion throughout both early and late
phases of the glucose stimulatory period (27), which was also
confirmed in MIN6B1 cells (Fig. 7, A and B). In view of these
results and previous reports indicating the involvement of F-ac-
tin remodeling in stimulated insulin secretion (17, 20, 22, 42)
andmore specifically in dense-core vesicle transport and dock-
ing at the plasma membrane (21, 43, 44), we investigated
whether FAK activity affects docking of insulin granules to the
plasma membrane. For this purpose we transfected MIN6B1
cells with a construct expressing the fluorescent fusion protein
NPY-Cherry to label dense-core vesicles (45, 46). Two days
after transfection, cells were incubated for 2 h at 0 mM glucose
in the presence of compoundY15 (1M, orDMSOas a negative
FIGURE 5.Specific FAK inhibitionwith compoundY15blocks glucose-inducedactin cytoskeleton remodeling.A, MIN6B1 cellswere preincubated for 2 h
in thepresence of 0mMglucosewith 1MY15 (orDMSO, as a negative control) andwere further treated for 10minwith 0 or 20mMglucose combinedwith Y15
(orDMSO). Cellswere subsequently fixed and stained for actin (withphalloidin). All images are fully representativeof four independent experiments.B,MIN6B1
cells expressing Lifeact-mRFPruby were stimulated with 20 mM glucose in combination with 1 M Y15 (or DMSO, as a negative control) and analyzed by live
microscopy. Images were captured every 60 s. Numbers indicate time (minutes) after stimulation. Scale bars, 10 m. See supplemental Movies 1 and 2; time 0
indicates the stimulation with 20 mM glucose in combination with DMSO (supplemental Movie 1) or Y15 (supplemental Movie 2).
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control), stimulated for 10 min with 20 mM glucose combined
with Y15 (or DMSO), fixed, and observed by TIRFmicroscopy.
In both basal and stimulated (10 min stimulation) conditions
we counted a significant reduction in the number of plasma
membrane-docked vesicles (Fig. 7, C and D) by FAK inhibition
(Y15) as compared with the control condition (DMSO), sug-
gesting that active FAK allows docking of insulin-containing
granules to the plasma membrane, presumably through actin
cytoskeleton remodeling.
Rac1 Is Involved in Glucose-induced Focal Adhesion and
Actin Cytoskeleton Remodeling in MIN6B1 Cells—In muscle
and adipose cells, insulin signaling downstream of PI3K, a
known substrate of FAK, bifurcates into at least two separate
arms, both involved in glucose transporter-4 translocation to
the plasmamembrane. The first arm involves the small GTPase
Rac1 leading to actin remodeling (47), whereas the second one
involves activation of Akt and its substrate AS160 (48, 49). To
study the possible involvement of Rac1 in glucose-induced
focal adhesion and actin remodeling in  cells, we used the
chemical compound NSC23766 that specifically binds to Rac1
at theTiambinding pocket, thereby preventingRac1 activation.
Due to the relatively slow rates of uptake of this compound as
reported in  cells (50) and other cell types (51, 52), MIN6B1
cells were cultured overnight at 10mMglucosewith either vehi-
cle alone or NSC23766 (50 M). This Rac1 inhibitor has been
shown to significantly attenuate GSIS in INS832/13  cells and
isolated islets (50), which was confirmed by us inMIN6B1 cells
(data not shown). Analysis of the phosphorylation status of
FAK, paxillin, and ERK1/2 in glucose-stimulated  cells
revealed a 28.1  11.8, 20.3  4.1, and 24.0  8.4% reduction,
respectively, in glucose-induced phosphorylation of these three
proteins in the presence of NSC23766 (Fig. 8A). This coincided
with a decreased glucose-induced formation of phospho-FAK-
and paxillin-containing focal adhesions as illustrated by the
confocal images in Fig. 8B, confirming the earlier described role
of Rac1 in the maintenance of focal adhesion complexes in
other cell types (53, 54). As shown in the actin panels of Fig. 8B,
treatment with NSC23766 also altered glucose-induced actin
cytoskeleton remodeling but not as drastically as observed in
case of FAK inhibition with compound Y15 (Fig. 5), suggesting
the involvement of other players in addition to Rac1 in the
regulation of glucose-induced actin remodeling downstream of
FAK. Finally, immunofluorescence experiments performed on
MIN6B1 cells expressing wild type Rac1 illustrate that treat-
ment with compound Y15 substantially altered the basal mem-
brane-associated localization of Rac1 in glucose-stimulated
cells (Fig. 8C). In conclusion, these results indicate the impor-
tance of Rac1 activity in glucose-induced focal adhesion and
actin remodeling in  cells but also suggest the involvement of
FAK in glucose-mediated Rac1 function in  cells.
Glucose-induced FAK Activation Acts Upstream of the Akt/
AS160 Signaling Pathway in MIN6B1 Cells—We have shown
previously that AS160 phosphorylation plays an important role
in GSIS (55). Accordingly, we investigated whether FAK activ-
ity, aside from regulating glucose-induced actin remodeling,
also affected the Akt/AS160 signaling pathway downstream of
PI3K in glucose-stimulated  cells. MIN6B1 cells were prein-
cubated for 2 h at 0 mM glucose in the presence of compound
Y15 (1M, or DMSO as a negative control) and then stimulated
for 10 min with 20 mM glucose containing compound Y15 (or
DMSO). Analysis of the phosphorylation status of Akt (Ser-
473) andAS160 (Ser/Thr) byWestern blot revealed a 50.6 9.8
and 75.2 8.0% (p 0.01) reduction, respectively, in glucose-
induced phosphorylation of both factors by FAK inhibition as
compared with the control stimulated condition (Fig. 9, A and
B), indicating that FAK-mediatedPI3Kwas effectively inhibited
and could not exert its effect on its downstream substrates.
These data suggest that FAK activity might indeed not only
regulate the insulin secretory machinery through actin cyto-
skeleton remodeling but also through the Akt/AS160 signaling
pathway.
DISCUSSION
The ECM is well known to be a critical regulator of  cell
function and survival (56, 57). Cell-matrix contacts are enabled
by specific focal adhesion sites providing both initiation points
for outside-in signaling and a structural link between ECM
components and the actin cytoskeleton (25, 26). Both FAK and
FIGURE 6. Compound Y15-mediated FAK inhibition stabilizes the associ-
ation of SNAP-25with F-actin. A, MIN6B1 cells were preincubated for 2 h in
the presence of 0mM glucose with 1M Y15 (or DMSO, as a negative control)
and were further treated for 10 min with 0 or 20 mM glucose combined with
Y15 (or DMSO). Precleared whole-cell detergent extracts were prepared and
immunoprecipitated (IP) with an anti-SNAP-25 monoclonal antibody (1–2
g/mg lysate protein). Lysates and immunoprecipitates were immuno-
blotted with the indicated antibodies. A representative blot from four inde-
pendent experiments is shown. Identical amounts of proteinswere analyzed,
and as a control, relative quantities of actin in cell lysates are shown. B, the
relative intensities of the immunoprecipitated actin bands (IP SNAP-25) were
quantified by densitometry andwere then normalized to the respective actin
bands in the cell lysates. Data are the means  S.E. from four independent
experiments (*, p 0.05).
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paxillin are focal adhesion proteins shown to be phosphory-
lated and activated upon ECM adhesion (30, 58) and more spe-
cifically to play a central role in the rapid actin remodeling that
is seen in  cells upon glucose stimulation (27). We have dem-
onstrated previously that both FAK and paxillin are implicated
in GSIS in primary  cells (27). In this study we further explore
the FAK/paxillin-ERK signaling pathway in glucose-stimulated
 cells and focus on a mechanistic link between FAK activity
and the insulin secretorymachinery through regulation of actin
cytoskeleton remodeling.
Cellular receptors involved in cell-ECM interactions mainly
belong to the integrin family (59), of which 1 integrin is the
most extensively studied in islet cell biology. In previous studies
both integrins 31 and 61 have been shown to mediate
attachment and spreading of rat pancreatic  cells, improving
cell survival and insulin secretion (29, 30, 60). In this study we
have demonstrated that 1 integrin co-localizes in response to
glucose and KCl with FAK and paxillin at specific focal adhe-
sion sites at the basal  cell membrane and that 1 integrin
intracellular signaling upon glucose stimulation involves the
activation of FAK, paxillin, and ERK1/2 in cells. These data, in
addition to earlier studies on cell survival (31, 61) and GSIS (29,
30, 62), indicate the importance of the 1 integrin-FAK-ERK
signaling pathway in  cells. Furthermore, blocking of this
pathway has also been shown to diminish focal contact sites and
to induce the formation of aggregated actin filaments, illustrat-
ing its function as amolecular scaffold linking integrinswith the
actin cytoskeleton in islet cells (31). Adding to this and in agree-
ment with previous reports (63–66), both latrunculin B and
jasplakinolide, through disruption of the dynamic equilibrium
between monomeric G-actin and filamentous F-actin states by
unilateral actin depolymerization and polymerization, respec-
tively, blocked glucose-induced mobilization of FAK and pax-
illin to focal adhesion sites as well as their activation, indicating
the importance of the dynamic remodeling of the actin cyto-
skeleton regarding FAK and paxillin signal transduction. As for
FIGURE 7. FAK inhibition attenuates glucose-stimulated insulin secretion anddecreases thenumber of secretory vesicles at theplasmamembraneof
MIN6B1 cells. A, MIN6B1 cells were preincubated for 2 h with 0mM glucose with compound Y15 (or DMSO). Cells were then incubated with low (0mM, basal)
followedbyhigh (20mM, stimulated) glucosewith orwithout Y15 for 1 h. Insulin secretion is expressed as apercentageof total insulin cell content. Data are the
mean S.E. from three independent experiments; *, p 0.01 versus control at same glucose concentration. B, cells were incubated as described above but
were stimulatedwith high glucosewith Y15 (or DMSO) for the indicated times. Data are expressed as themean S.E. from three independent experiments; *,
p 0.05 versus Y15-treated cells. C, MIN6B1 cells transfectedwith a plasmid expressing NPY-Cherry were preincubated for 2 h in the presence of 0mMglucose
with 1 M Y15 (or DMSO, as a negative control) and were further stimulated for 10 min with 20 mM glucose combined with Y15 (or DMSO). Cells were
subsequently fixed and analyzed by TIRF microscopy. Representative TIRF images of the plasma membrane of MIN6B1 cells transfected with a NPY-Cherry
plasmid are shown. Scale bars, 5 m. D, the number of secretory vesicles detected by TIRF at the plasma membrane and the plasma membrane surface area
were quantified byMetaMorph Version 6.0 and expressed as a ratio. Ratios were then normalized to the control condition (DMSO). Data are themeans S.E.
from three independent experiments (*, p 0.01).
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ERK1/2, we observed that latrunculin B and jasplakinolide
potentiated and inhibited its glucose-induced activation,
respectively, suggesting that glucose-induced ERK1/2 activa-
tion is dependent on the actin polymerization state. Note, how-
ever, the less pronounced inhibitory effect of jasplakinolide on
glucose-induced phosphorylation of ERK1/2 as compared with
that on FAK and paxillin. These data indicate the involvement
of additional signaling pathways in glucose-induced ERK1/2
activation in  cells.
Numerous reports on  cells (for review, see Ref. 67) support
the working model where F-actin, organized as a dense barrier
beneath the plasmamembrane, undergoes reorganization upon
glucose stimulation to allow insulin-containing granules access
to the cell periphery. In this study we show that FAK activity
plays a crucial role in glucose-induced actin cytoskeleton
remodeling andGSIS by using a selective inhibitor of FAKauto-
phosphorylation at Tyr-397 (38, 39). The inhibitory effect of
latrunculin B and jasplakinolide on glucose-induced activation
FIGURE 8. Rac1 is involved in glucose-induced focal adhesion and actin remodeling in MIN6B1 cells. A, MIN6B1 cells were cultured overnight at 10 mM
glucose with the Rac1 inhibitor NSC23766 (50 M) or vehicle (H2O) alone (control). Cells were then preincubated for 2 h with 0 mM glucose combined with
NSC23766 (50 M) or vehicle as a control and were further stimulated for 10 min with 20 mM glucose with NSC23766 or vehicle. Cell lysates were analyzed by
Western blot with the indicated antibodies, and relative intensities of the phosphorylated and total protein bands were quantified by densitometry and
expressed as a ratio. Ratios were then normalized to control high glucose (20 mM glucose)-stimulated cells. Data are themeans S.E. from four independent
experiments (*, p 0.05; **, p 0.01). B, MIN6B1 cells were treated as described above, fixed, and stained for phospho-FAK (green), paxillin (red), and F-actin
(blue). All pictures are fully representative of multiple images from three independent experiments. Scale bars, 10m. C, MIN6B1 cells expressingmyc-tagged
wild type Rac1were preincubated for 2 hwith 0mM glucosewith 1M compound Y15 (or DMSO as a negative control) andwere further stimulated for 10min
with 20 mM glucose combined with Y15 (or DMSO). Cells were subsequently fixed and stained for myc-tag (green) and F-actin (blue). All pictures are fully
representative of multiple images from three independent experiments. Scale bars, 10 m.
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of FAK that we show here taken together with their previously
described stimulatory effect on cortical actin rearrangement
and GSIS (20, 21) suggests that both actin-disrupting agents
“shortcut” the regulatory role of FAK. More specifically, these
data indicate FAK to act upstream of glucose-induced actin
cytoskeleton remodeling but also point to a feedback loop from
actin remodeling back to focal adhesion remodeling, illustrated
by the inhibitory effect of chemical actin disruption on FAK
autophosphorylation and focal adhesion assembly. This mech-
anism thereby allows both FAK inhibition, through blocking of
actin remodeling, to attenuate glucose-stimulated insulin
secretion and latrunculin B and jasplakinolide treatment, by
actin rearrangement and independent from its effect on FAK
activity, to potentiate glucose-stimulated insulin secretion.
This regulatory role of FAKon actin organizationwas further
confirmed by our findings that FAK inhibition blocks glucose-
induced disruption of the F-actin/SNAP-25 association at the
plasma membrane. This interaction model, proposed by Thur-
mond et al. (21), suggests that glucose stimulation of  cells
induces the transient remodeling of cortical F-actin, disengag-
ing actin tethering to the SNARE complex, thereby promoting
granule docking/fusion and exocytosis. In addition, TIRF-me-
diated visualization of insulin secretory vesicles revealed a
reduction in the number of insulin-containing granules adja-
cent to the plasma membrane due to FAK inhibition. All
together, these data suggest that FAK is crucial for glucose-
induced actin cytoskeleton remodeling to allow insulin-con-
taining vesicles to get in close proximity to the plasma mem-
brane, a necessary step for docking and fusion. This correlates
with the inhibitory effect of FAK inhibition on both early and
late phases ofGSIS, suggesting a functional role for FAKboth in
the regulation of the number of docked insulin granules as well
as in mobilization of insulin granules to the plasmamembrane.
These observations are consistent with the regulatory function
of FAK in insulin-induced actin reorganization and glucose
transporter-4 translocation in skeletal muscle cells (41).
Recent studies performed on neuroendocrine chromaffin
cells reported the association of SNARE protein patches and
clusters of voltage-gated Ca2 channels with the borders of
cortical cytoskeletal cages (68, 69). We show here the glucose-
responsive colocalization of Ca2-responsive FAK (27) with 1
integrin and paxillin in patches at the basal  cell membrane.
Considering this and the earlier reported cluster-like distribu-
tion of the SNARE proteins syntaxin 1 and SNAP-25 (70),
which interact with both L-type Ca2 channels and actin in 
cells (71, 72), it will be interesting in the future to explore the
presence of similar cortical cytoskeletal cages in  cells and
their possible association with FAK. This might clarify the
mechanistic link between FAK activity and the organization of
the actin cytoskeleton and might thereby further explain its
effect on the insulin secretory machinery. In addition, the pres-
ence of Ca2 “hotspots” (73), shown to associate with the bor-
ders of these cytoskeletal cages (68), would also elucidate the
local actin remodeling-mediated activation of ERK1/2 we dem-
onstrate here.
Finally, we show here for the first time the negative effect of
FAK inhibition on two signaling pathways downstream of PI3K
in glucose-stimulated  cells, namely the Rac1 and the Akt/
AS160 signaling pathways. Rac1 is a member of the Rho sub-
family of G-proteins known to play a regulatory role in GSIS
(50, 74–77). Considering the study of the cellular distribution
of Rac1 in glucose-stimulated  cells by Li et al. (77), we
observed that FAK inhibition clearly altered the basal mem-
brane-associated localization of Rac1, suggesting FAK to be
involved in glucose-mediated Rac1 activation. Based on its well
known role in cytoskeletal rearrangement and our results pre-
FIGURE 9. Inhibitionof FAKattenuates glucose-inducedphosphorylationofAkt andAS160 inMIN6B1 cells.MIN6B1 cellswere preincubated for 2 hwith
0 mM glucose combined with compound Y15 (1 M, or DMSO as a negative control) and were further stimulated for 10 min with 20 mM glucose with Y15 (or
DMSO). A, cell lysates were analyzed by Western blot with the indicated antibodies, and a representative blot from four independent experiments is shown.
B, the relative intensities of thephosphorylated and total proteinbandswerequantifiedbydensitometry andexpressed as a ratio. Ratioswere thennormalized
to control high glucose (20 mM glucose)-stimulated cells. Data are the means S.E. from four independent experiments (*p 0.01; **, p 0.001).
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sented here, Rac1 might thereby act as a factor linking glucose-
induced FAK activation and actin cytoskeleton remodeling in
the regulation of the insulin secretory machinery in  cells.
Furthermore, results obtainedwith the Rac1 inhibitor also indi-
cated the regulatory role for Rac1 in focal adhesion assembly,
which is supported by earlier studies performed in other cell
types (53, 54) and which also confirms the observed mutual
interaction between glucose-induced focal adhesion and actin
cytoskeleton remodeling in  cells as mentioned above.
In agreement with the role of Akt and AS160 in the regula-
tion of glucose transporter-4 vesicle trafficking in muscle cells
and adipocytes (49, 78–81) and the functional role of AS160 in
GSIS in  cells (55), we hypothesize that FAK might also, aside
from its effect on actin remodeling, impact on vesicle provision
from the reserve pool or docking/fusion efficiency of the secre-
tory vesicles with the plasma membrane through regulation of
the Akt/AS160 signaling pathway. However, further investiga-
tion will be necessary to unravel the exact mechanism.
In summary, this study proposes a model of how glucose-
induced, 1 integrin-mediated FAK activation contributes to
the regulation of the insulin secretory machinery through actin
cytoskeleton remodeling, showing many similarities with the
insulin-induced glucose transporter-4 translocation mecha-
nism in muscle cells and adipocytes. Further studies will be
necessary to further characterize this signaling pathway, which
may facilitate the discovery of new targets for the treatment of
diabetes.
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